Frontlight ResearchEarly access
Trial site
Charter Research The Villages
- 6running trials
- 3closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Obesity2 trials
- Type 2 diabetes2 trials
- Bladder cancer1 trial
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Lung cancer1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 24 trials
- Phase 34 trials
- Status
- Recruiting4 trials
- Completed3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Amgen2 trials
- Eli Lilly and Company2 trials
- AriBio Co., Ltd.1 trial
- Delfi Diagnostics Inc.1 trial
- Hanmi Pharmaceutical Company Limited1 trial
- and 2 more
Running trials
Recruiting
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Recruiting
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Recruiting
Active, not recruiting
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Type 2 diabetes2 recruiting
- Alzheimer disease1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026